Kate Marie Shamsuddin - Feb 14, 2024 Form 4 Insider Report for Definitive Healthcare Corp. (DH)

Role: CHIEF PRODUCT OFFICER
Signature: /s/ Matthew Ruderman, Attorney-in-Fact
Stock symbol: DH
Transactions as of: Feb 14, 2024
Transactions value $: $0
Form type: 4
Date filed: 2/16/2024, 04:16 PM
Previous filing: Feb 5, 2024
Next filing: Mar 18, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DH	Class A Common Stock	Award	$0	+122K	+59.72%	$0.00	326K	Feb 14, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001. The RSUs vest over a four-year period, with 25% of the RSUs vesting on February 1, 2025, followed by quarterly vesting of 6.25% every three months thereafter over the subsequent three years, in each case subject to the Reporting Person's continued service with the Issuer through each such vesting date.

Content

Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001. The RSUs vest over a four-year period, with 25% of the RSUs vesting on February 1, 2025, followed by quarterly vesting of 6.25% every three months thereafter over the subsequent three years, in each case subject to the Reporting Person's continued service with the Issuer through each such vesting date.